Literature DB >> 17910083

A year of unprecedented progress in Down syndrome basic research.

Roger H Reeves1, Craig C Garner.   

Abstract

The years 2006 and 2007 saw the publication of three new and different approaches to prevention or amelioration of Down syndrome effects on the brain and cognition. We describe the animal model systems that were critical to this progress, review these independent breakthrough studies, and discuss the implications for therapeutic approaches suggested by each. 2007 Wiley-Liss, Inc.

Mesh：

Substances：

Year:  2007        PMID： 17910083     DOI： 10.1002/mrdd.20165

Source DB:  PubMed          Journal:  Ment Retard Dev Disabil Res Rev        ISSN： 1080-4013


  15 in total

Review 1.  Trisomy 21 and early brain development.

Authors:  Tarik F Haydar; Roger H Reeves
Journal:  Trends Neurosci       Date:  2011-12-09       Impact factor: 13.837

2.  The Down syndrome critical region regulates retinogeniculate refinement.

Authors:  Martina Blank; Peter G Fuerst; Beth Stevens; Navid Nouri; Lowry Kirkby; Deepti Warrier; Ben A Barres; Marla B Feller; Andrew D Huberman; Robert W Burgess; Craig C Garner
Journal:  J Neurosci       Date:  2011-04-13       Impact factor: 6.167

3.  Hedgehog agonist therapy corrects structural and cognitive deficits in a Down syndrome mouse model.

Authors:  Ishita Das; Joo-Min Park; Jung H Shin; Soo Kyeong Jeon; Hernan Lorenzi; David J Linden; Paul F Worley; Roger H Reeves
Journal:  Sci Transl Med       Date:  2013-09-04       Impact factor: 17.956

4.  How to correct chromosomal trisomy.

Authors:  Christine M Disteche
Journal:  Cell Res       Date:  2013-10-01       Impact factor: 25.617

Review 5.  Down syndrome and the complexity of genome dosage imbalance.

Authors:  Stylianos E Antonarakis
Journal:  Nat Rev Genet       Date:  2016-12-28       Impact factor: 53.242

6.  Disruption of neurogenesis and cortical development in transgenic mice misexpressing Olig2, a gene in the Down syndrome critical region.

Authors:  Wei Liu; Hui Zhou; Lei Liu; Chuntao Zhao; Yaqi Deng; Lina Chen; Laiman Wu; Nicole Mandrycky; Christopher T McNabb; Yuanbo Peng; Perry N Fuchs; Jie Lu; Volney Sheen; Mengsheng Qiu; Meng Mao; Q Richard Lu
Journal:  Neurobiol Dis       Date:  2015-03-05       Impact factor: 5.996

7.  Parental Perspectives on Pharmacological Clinical Trials: a Qualitative Study in Down Syndrome and Fragile X Syndrome.

Authors:  Victoria Reines; Krista Charen; Tracie Rosser; Arri Eisen; Stephanie L Sherman; Jeannie Visootsak
Journal:  J Genet Couns       Date:  2017-05-24       Impact factor: 2.537

Review 8.  A Sonic hedgehog (Shh) response deficit in trisomic cells may be a common denominator for multiple features of Down syndrome.

Authors:  Duane G Currier; Renita C Polk; Roger H Reeves
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

9.  PCR prescreen for genotyping the Ts65Dn mouse model of Down syndrome.

Authors:  Hernan Lorenzi; Nichole Duvall; Sheila M Cherry; Roger H Reeves; Randall J Roper
Journal:  Biotechniques       Date:  2010-01       Impact factor: 1.993

10.  A new mouse model for the trisomy of the Abcg1-U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome.

Authors:  Patricia Lopes Pereira; Laetitia Magnol; Ignasi Sahún; Véronique Brault; Arnaud Duchon; Paola Prandini; Agnès Gruart; Jean-Charles Bizot; Bernadette Chadefaux-Vekemans; Samuel Deutsch; Fabrice Trovero; José María Delgado-García; Stylianos E Antonarakis; Mara Dierssen; Yann Herault
Journal:  Hum Mol Genet       Date:  2009-09-26       Impact factor: 6.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.